
73. Who Pays for Multimillion-Dollar Miracle Cures?
Freakonomics, M.D.
Sickle Cell Disease
The CRISPR-based treatment that cured Jimmy Olaher is now up for FDA approval. If our drug financing landscape doesn't change, the cure will remain out of reach for many patients who need it. Imagine a future where organizations and governments across the globe collaborate to eradicate sickle cell disease everywhere. Like they pledged to do with polio, 33 years after an American scientist developed the first successful vaccine.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.